Cochlear Limited attended the CES for the first time this year, showcasing a virtual reality demo and an opportunity to speak with implant recipients. They showcased their Nucleus 7 Implant and ...

CENTENNIAL, Colo., April 7, 2020 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, obtained U.S. Food and Drug Administration (FDA) approval on April ...

Cochlear is the global leader in implantable hearing solutions. The company has a global workforce of more than 3,500 people and invests more than AUD$160 million each year in research and ...

Cochlear anticipates Remote Assist approval in Canada to be obtained in late 2021 for the Nucleus System and early 2022 for the Baha System.

With the Nucleus 7 processor cochlear implant, individuals can choose from several additional features, including different wireless hearing capabilities, a mini microphone, a phone clip, and TV ...

The Nucleus 7 sound processor will allow users to stream sounds directly to their Cochlear implant from their iPhone, iPad and iPod touch. SEE ALSO: 'See' sounds around you with these eyeglasses ...